-
Mashup Score: 0Geographic And Demographic Variations in Hepatitis C Mortality - 12 hour(s) ago
Data from the 2023 CDC surveillance report highlights key differences in death rates across states and populations, informing targeted public health efforts.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0Value of Sputum Cultures Diminished by Prior Antibiotics - 17 hour(s) ago
Study underscores value of obtaining sputum culture prior to initiating antibiotics, for greater detection of pathogens without opportunistic bacteria of uncertain clinical relevance.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
Dr. Magnus Paulsson from @lunduniversity on his study that sputum cultures taken before antibiotics are far more likely to identify true respiratory pathogens and less likely to yield misleading opportunists. Better diagnostics = smarter stewardship. https://t.co/pCYCdZWIMU
-
-
Mashup Score: 8A Passion For Infectious Disease Education and Communication - 1 day(s) ago
In our latest podcast, Tim Gauthier, PharmD, BCPS, BCIDP, discusses all things pathogens and antibiotics. He also details the opportunities presented for antimicrobial stewardship when it combines diagnostics and treatment duration.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
In our latest podcast, Dr. Tim Gauthier discusses all things pathogens and antibiotics. He talks with Dr. @RodneyRohde about opportunities presented for stewardship when it combines diagnostics and treatment duration.@IDstewardship #IDtwitter #MedTwitter https://t.co/GdtiWDLUZo
-
-
Mashup Score: 0IDWeek 2024 Review: Shionogi's Antibiotic for Use in Adults with Certain Gram-negative Bacterial Infections - 1 day(s) ago
Contagion® is a news resource for infectious disease specialists and practitioners, aiding identification, diagnosis, treatment and prevention.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
In case you missed it: New data from PROVE, the largest global real-world study on @ShionogiUS's antibiotic for use in adults with certain Gram-negative bacterial infections. Learn more: https://t.co/I69Td094Dv #Sponsored https://t.co/jYV8QcmaP5
-
-
Mashup Score: 9
In an early release of his Summer issue’s letter, Editor-in-Chief Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, discusses the recent changes to the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), and where professional societies must step in and lead with research data and clinical guidance in the absence of experienced committee members.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
In an early release of his letter for the Summer issue, Editor-in-Chief Dr. Jason Gallagher, discusses the recent changes to the CDC's ACIP, and where professional societies must step in and lead. #IDtwitter #MedTwitter https://t.co/yApObYmAtx
-
-
Mashup Score: 0Contagion Live | Infectious Disease News & Expert Insights - 2 day(s) ago
Contagion® is a fully integrated news resource for practitioners and specialists to assist with the identification, diagnosis, treatment, and prevention of infectious diseases.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
It’s day 3 of #IDWeek2023! Which presentations have you found most exciting so far? For live coverage from Boston, check out https://t.co/E1VM7WHKKY https://t.co/BeSzLKhUBV
-
-
Mashup Score: 0
Successful HCV treatment with DAAs was associated with reduced risks of CKD, stroke, major adverse cardiac events, and neurocognitive disorders.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
#HCV treatment w/ DAAs reduces the risk of stroke, CKD, major cardiac events, and neurocognitive disorders, according to a study led by Dr. Naveed from the BC CDC. This article was originally posted on our sister site, @HCPLiveNews https://t.co/WEnU8dUi7H
-
-
Mashup Score: 0
Jatin Vyas, PhD, MD, offers some insights into the economics of development, the biology of fungal species, and the difficulties behind creating new antifungal molecules.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
.@jmvyasmdphd offers some insights into the economics of development, the biology of fungal species, and the difficulties behind creating new antifungal molecules. #IDtwitter #MedTwitter https://t.co/CbhvT6aOu7
-
-
Mashup Score: 4FDA Expands Indication for AbbVie’s Antiviral as First Treatment for People With Acute Hepatitis C - 4 day(s) ago
The antiviral, glecaprevir/pibrentasvir (Mavyet), is the first and only oral 8-week pangenotypic treatment approved for people with acute or chronic hepatitis C. The approval supports global clinical guidelines to advance testing and treatment HCV regardless of chronicity, and supports public health goals for disease elimination.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
The antiviral, glecaprevir/pibrentasvir, is the first and only oral 8-week pangenotypic treatment approved for people with acute or chronic hepatitis C. #IDtwitter #MedTwitter https://t.co/rj5RHl7O21
-
-
Mashup Score: 2
Innoviva and GARDP’s breakthrough treatment could become the first new gonorrhea antibiotic in decades amid rising antimicrobial resistance.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
Gonorrhea resistance is rising, ceftriaxone resistance hit 8.1% in China. Now, the FDA has accepted the NDA for zoliflodacin, a first-in-class oral antibiotic backed by GARDP & Innoviva. A major step in the AMR fight. Read more: https://t.co/qIxAz9yn4N https://t.co/1f2G8Nb06E
-
@CDCgov data reveal wide variations in Hepatitis C death rates across states & populations, w/ the highest mortality among older adults, men, & American Indian/Alaska Native groups, highlighting the need for targeted public health actions to reduce deaths. https://t.co/Rifsf5ZdRv